Compare studies and check their requirements with the research team.
This study is completed in the United States. It focuses on schizophrenia.
In United StatesThis study is completed in the United States and in India. It focuses on schizophrenia.
In United StatesThis study is completed in the United States. It focuses on ADHD.
In United States
This study is completed in the United States. It focuses on Schizophrenia.
In United StatesThis study is completed in the United States, in Bulgaria, in Poland, .... It is testing roluperidone for schizophrenia.
In United StatesThis study is completed in the United States. It is testing ropanicant for Depression.
In United StatesThis study is completed in the United States. It is testing NRCT-101SR for ADHD.
In United StatesThis study was terminated in the United States. It is testing NRCT-101SR for ADHD.
In United States
This study is completed in the United States. It is testing potential Predictors of Relapse for depression.
In United StatesThis study is completed in the United States. It is testing Safety & Efficacy of d-Amphetamine Transdermal System for ADHD.
In United StatesThis study was terminated in the United States. It is testing safety & Efficacy of NaBen® for schizophrenia.
In United StatesThis study is completed in the United States. It focuses on ADHD.
In United StatesHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.